Udo Jonas

Udo Jonas's AcademicInfluence.com Rankings

Udo Jonas

Philosophy

#8896

World Rank

#12361

Historical Rank

Logic

#5907

World Rank

#7358

Historical Rank

philosophy Degrees

Udo Jonas

Biology

#12132

World Rank

#15587

Historical Rank

Neuroscience

#2021

World Rank

#2077

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Udo Jonas's Degrees

Doctorate Medicine Stanford University

Why Is Udo Jonas Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Udo Jonas's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. (2007) (501)
Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder. (2001) (442)
SACRAL NERVE STIMULATION FOR TREATMENT OF REFRACTORY URINARY URGE INCONTINENCE (1999) (405)
Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. (2000) (388)
Monoclonal antibody G 250 recognizes a determinant present in renal‐cell carcinoma and absent from normal kidney (1986) (378)
Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project. (2002) (351)
Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. (2001) (318)
Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume. (2007) (227)
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). (2004) (219)
Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. (2001) (199)
Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. (1999) (188)
Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. (2008) (186)
Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability (2003) (166)
Endoscopic extraperitoneal radical prostatectomy: oncological and functional results after 700 procedures. (2005) (160)
Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit. (1991) (160)
Long–Term Effectiveness of Sacral Nerve Stimulation for Refractory Urge Incontinence (2000) (154)
p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. (1995) (149)
Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men (2002) (146)
Expression of the p53 and maspin protein in primary prostate cancer: Correlation with clinical features (2001) (129)
Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. (2004) (123)
Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue. (2000) (122)
Ultrasound measurement of detrusor wall thickness in healthy adults (2006) (118)
Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma. (1986) (110)
The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo. (1998) (108)
Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: From bench to bedside (2001) (107)
Quantitation of DNA extracted after micropreparation of cells from frozen and formalin-fixed tissue sections. (2000) (107)
Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. (2006) (105)
Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials (2001) (105)
The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms (2008) (103)
Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence. (2001) (102)
Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate. (2006) (101)
Male Lower Urinary Tract Symptoms and Related Health Care Seeking in Germany (2001) (101)
Endoscopic extraperitoneal radical prostatectomy: initial experience after 70 procedures. (2003) (100)
Biological vascularized matrix for bladder tissue engineering: matrix preparation, reseeding technique and short-term implantation in a porcine model. (2005) (98)
Oral phentolamine as treatment for erectile dysfunction. (1998) (98)
Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle (1996) (93)
Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours (2005) (93)
Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. Analysis of a multinational, multicentre, open-label study assessing the long-term efficacy and safety in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group. (1996) (91)
Neuromodulation of voiding dysfunction and pelvic pain (1991) (89)
Long-term safety, tolerability and efficacy of extended-release tolterodine in the treatment of overactive bladder. (2002) (87)
Evolution of endoscopic extraperitoneal radical prostatectomy (EERPE)—technical improvements and development of a nerve-sparing, potency-preserving approach (2003) (85)
Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation (1998) (80)
Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction. (2001) (79)
Preliminary results with the nitric oxide donor linsidomine chlorhydrate in the treatment of human erectile dysfunction. (1992) (77)
Expression of different phosphodiesterase genes in human cavernous smooth muscle. (2001) (74)
Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile dysfunction (2001) (74)
Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. (1999) (73)
Congenital and Acquired Penile Deviation Treated with the Essed Plication Method (2000) (73)
Silicone-silver penile prosthesis: description, operative approach and results. (1980) (72)
Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue. (2008) (72)
Oncological and functional results of open, robot-assisted and laparoscopic radical prostatectomy: does surgical approach and surgical experience matter? (2007) (70)
Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence (2008) (70)
RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis (2007) (68)
Tamsulosin: 3-Year Long-Term Efficacy and Safety in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Analysis of a European, Multinational, Multicenter, Open-Label Study (1999) (68)
Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer (2006) (67)
Initial clinical experience with the selective phosphodiesterase-I isoenzyme inhibitor vinpocetine in the treatment of urge incontinence and low compliance bladder (2000) (66)
Calcitonin-gene-related peptide: a possible role in human penile erection and its therapeutic application in impotent patients. (1991) (65)
Twelve-Month Treatment of Overactive Bladder (2001) (64)
Androgen and estrogen receptors in the human corpus cavernosum penis: immunohistochemical and cell culture results (2003) (64)
The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience (2002) (60)
p53 overexpression as a prognostic factor for advanced stage bladder cancer. (1995) (60)
Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction. (1994) (59)
The prediction of clinical outcome from transurethral microwave thermotherapy by pressure-flow analysis: a European multicenter study. (1995) (58)
Surgery for metachronous solitary liver metastases of renal cell carcinoma. (1997) (57)
Interactions between cGMP- and cAMP-pathways are involved in the regulation of penile smooth muscle tone (2004) (56)
The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy. (1998) (54)
Prognostic factors for the postoperative outcome of penile venous surgery for venogenic erectile dysfunction. (1994) (52)
Single potential analysis of cavernous electrical activity in impotent patients: a possible diagnostic method for autonomic cavernous dysfunction and cavernous smooth muscle degeneration. (1991) (52)
Tolterodine: an overview (2001) (52)
Urethral closure mechanism under stress conditions. (1979) (51)
Effects of visual sexual stimuli and apomorphine SL on cerebral activity in men with erectile dysfunction. (2003) (51)
Complications of endoscopic extraperitoneal radical prostatectomy (EERPE): prevention and management (2006) (50)
The effect of the specific phosphodiesterase-IV-inhibitor rolipram on the ureteral peristalsis of the rabbit in vitro and in vivo. (1998) (50)
Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients (1999) (49)
The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer. (2005) (48)
Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide-dependent pathways (2000) (48)
Urinary tract injuries in patients with multiple trauma (2007) (47)
Adiposity and Age are Statistically Related to Enhanced RASSF1A Tumor Suppressor Gene Promoter Methylation in Normal Autopsy Kidney Tissue (2007) (46)
Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle (2005) (46)
Isolation of primary endothelial and stromal cell cultures of the corpus cavernosum penis for basic research and tissue engineering. (2005) (46)
Cyclic Nucleotide Phosphodiesterase (PDE) Isoenzymes in the Human Detrusor Smooth Muscle: II. Effect of Various PDE Inhibitors on Smooth Muscle Tone and Cyclic Nucleotide Levels In Vitro (1998) (46)
Long-term followup of children with colon conduit urinary diversion and ureterosigmoidostomy. (1977) (46)
Rejuvenation in the early 20th century (2009) (44)
Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle. I. Identification and characterization. (1998) (44)
Safety and efficacy of tolterodine extended release in men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia (2007) (44)
Effects of various nitric oxide-donating drugs on adrenergic tension of human seminal vesicles in vitro. (2003) (44)
Prognostic relevance of intracaval neoplastic extension for patients with renal cell cancer. (1997) (43)
Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis (2007) (43)
In vitro effects of a novel class of nitric oxide (NO) donating compounds on isolated human erectile tissue. (2002) (42)
Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis (1996) (42)
Uncircumcision: a historical review of preputial restoration. (1998) (42)
Followup results of a combination of calcitonin gene-related peptide and prostaglandin E1 in the treatment of erectile dysfunction. (1993) (41)
Metastatic renal cell carcinoma (RCC): Spontaneous regression, long-term survival and late recurrence (2006) (41)
Oxytocin plasma levels in the systemic and cavernous blood of healthy males during different penile conditions (2003) (41)
Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle (2004) (41)
Gene Expression of the Phosphodiesterases 3A and 5A in Human Corpus cavernosum Penis (2000) (41)
Immunohistochemical distribution of cyclic GMP-dependent protein kinase-1 in human prostate tissue. (2007) (40)
Management of the post‐chemotherapy residual mass in patients with advanced stage non‐seminomatous germ cell tumors (nsgct) (1999) (39)
Cavernous and systemic testosterone plasma levels during different penile conditions in healthy males and patients with erectile dysfunction. (2001) (39)
Sexual function and fertility after treatment of testicular cancer (2000) (39)
Conservative therapy of frequency, urgency and urge incontinence: A double-blind clinical trial of flavoxate hydrochloride, exybutinin chloride, emepronium bromide and placebo (1987) (38)
Categorisation of complications of endoscopic extraperitoneal and laparoscopic transperitoneal radical prostatectomy (2006) (38)
Possible role of bioactive peptides in the regulation of human detrusor smooth muscle – functional effects in vitro and immunohistochemical presence (2002) (37)
Long-term results following dorsal penile vein ligation in 126 patients with veno-occlusive dysfunction (1997) (36)
Expression of E-cadherin in primary prostate cancer: correlation with clinical features. (1998) (36)
Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro (1994) (36)
Does bone anchor fixation improve the outcome of percutaneous bladder neck suspension in female stress urinary incontinence? (1998) (35)
The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) (2005) (35)
Effect of flavoxate on hyperactive detrusor muscle. (1979) (35)
In vitro functional responses of isolated human vaginal tissue to selective phosphodiesterase inhibitors (2005) (34)
Cavernous and systemic plasma levels of norepinephrine and epinephrine during different penile conditions in healthy men and patients with erectile dysfunction. (2002) (34)
Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer. (2001) (34)
The MXI1 tumor suppressor gene is not mutated in primary prostate cancer. (1998) (34)
Functional Tissue Engineering of Autologous Tunica Albuginea: A Possible Graft for Peyronie’s Disease Surgery (2004) (34)
Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group. (1997) (33)
Transcutaneous registration of cavernous smooth muscle electrical activity: noninvasive diagnosis of neurogenic autonomic impotence. (1992) (33)
Functional responses of isolated human seminal vesicle tissue to selective phosphodiesterase inhibitors. (2007) (33)
Cyclic AMP-specific and cyclic GMP-specific phosphodiesterase isoenzymes in human cavernous arteries—immunohistochemical distribution and functional significance (2005) (33)
Is there an inhibitory role of cortisol in the mechanism of male sexual arousal and penile erection? (2003) (32)
Effects of various phosphodiesterase‐inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro (1996) (32)
Alfuzosin: a clinically uroselective α1-blocker (2002) (32)
Ureteric reconstruction (2003) (32)
Laparoscopy in German urology: changing acceptance among urologists. (2009) (32)
European studies of interleukin-2 in metastatic renal cell carcinoma. (1993) (32)
A possible role for nitric oxide in the regulation of human ureteral smooth muscle tone in vitro (2004) (32)
Indication and value of bladder neck incision. (1979) (32)
Cavernous and systemic testosterone levels in different phases of human penile erection. (2000) (31)
Immunocytochemical distribution of nitric oxide synthase in the human corpus cavernosum: an electron microscopical study using the tyramide signal amplification technique (2001) (31)
Determination of nitric oxide metabolites by means of the Griess assay and gas chromatography–mass spectrometry in the cavernous and systemic blood of healthy males and patients with erectile dysfunction during different functional conditions of the penis (2000) (31)
Responses of Isolated Normal Human Detrusor Muscle to Various Spasmolytic Drugs Commonly Used in the Treatment of the Overactive Bladder (2000) (31)
Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients (2006) (30)
Expression of messenger ribonucleic acid encoding for phosphodiesterase isoenzymes in human female genital tissues. (2007) (30)
ORIGINAL RESEARCH—HISTORY: Nikolaj A. Bogoraz (1874–1952): Pioneer of Phalloplasty and Penile Implant Surgery (2005) (30)
Tissue engineering from Adam to the zygote: historical reflections (2000) (30)
Serum levels of human growth hormone during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction. (2002) (30)
Possible role of human growth hormone in penile erection. (2000) (30)
Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study. (2006) (30)
Curiosity in urology? Masturbation injuries. (1980) (29)
Cyclic adenosine monophosphate and cyclic guanosine monophosphate-phosphodiesterase isoenzymes in human vagina: relation to nitric oxide synthase isoforms and vasoactive intestinal polypeptide-containing nerves. (2005) (29)
Intracavernous calcitonin gene-related peptide plus prostaglandin E1: possible alternative to penile implants in selected patients. (1994) (28)
Plasma levels of cavernous and systemic norepinephrine and epinephrine in men during different phases of penile erection. (2000) (28)
History of direct vision internal urethrotomy. (1998) (28)
Predictive value of real-time RigiScan monitoring for the etiology of organogenic impotence. (1993) (28)
The future of the oral pharmacotherapy of male erectile dysfunction: things to come (2007) (28)
Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro. (1995) (27)
Successful combination of transrectal electroejaculation and intracytoplasmic sperm injection in the treatment of anejaculation. (1996) (27)
The history of erectile dysfunction management (2001) (27)
Effects of various nitric oxide donating agents on the contractility and cyclic nucleotide turnover of human seminal vesicles in vitro. (2002) (27)
Phosphodiesterase isoenzymes in human ureteral smooth muscle: identification, characterization, and functional effects of various phosphodiesterase inhibitors in vitro. (1995) (27)
In Vitro Construction of Urinary Bladder Wall using Porcine Primary Cells Reseeded on Acellularized Bladder Matrix and Small Intestinal Submucosa (2003) (26)
Sacral electrical neuromodulation as an alternative treatment option for lower urinary tract dysfunction. (1999) (26)
Is serotonin significant for the control of penile flaccidity and detumescence in the human male? (2003) (26)
Homologous acellular matrix graft for vaginal repair in rats: a pilot study for a new reconstructive approach (2002) (25)
Perfusion of tumor-bearing kidneys as a model for scintigraphic screening of monoclonal antibodies. (1988) (25)
Telemetric urodynamic investigations in normal males. (1980) (25)
Review article Testosterone therapy in the ageing male: what about the prostate? (2004) (25)
Single potential analysis of cavernous electrical activity. Four years' experience in more than 500 patients with erectile dysfunction. (1993) (25)
Immunocytochemical distribution of nitric oxide synthase in the human seminal vesicle: a light and electron microscopical study (2003) (25)
Surgical principles of sacral foramen electrode implantation (1991) (25)
Electrical and chemical control of smooth muscle activity of rabbit corpus cavernosum in vitro. (1996) (24)
Erratum to: Systemic and cavernous plasma levels of endothelin (1–21) during different penile conditions in healthy males and patients with erectile dysfunction (2001) (24)
CHESS classification of bladder-outflow obstruction (1995) (24)
Urodynamics in benign prostatic hyperplasia (1996) (24)
[Phytotherapy of benign prostatic hyperplasia. Current evidence-based evaluation]. (2002) (23)
[Benign prostate hyperplasia]. (2006) (23)
In vitro functional responses of isolated normal human prostatic tissue to compounds interacting with the cyclic guanosine monophosphate pathway. (2006) (23)
Pilot study of the transdermal application of testosterone gel to the penile skin for the treatment of hypogonadotropic men with erectile dysfunction (2000) (23)
Partial unilateral penile thrombosis: magnetic resonance imaging and management. (1998) (22)
Non‐genomic effects of androgens on isolated human vascular and nonvascular penile erectile tissue (2007) (22)
A questionnaire-based outcome analysis of the Stamey bladder neck suspension procedure for the treatment of urinary stress incontinence: the Hannover experience. (1998) (22)
[Drug therapy of benign prostatic hyperplasia syndrome with alpha 1-receptor blockers. Basic principles and clinical results]. (2002) (22)
Systemic and cavernous plasma levels of vasoactive intestinal polypeptide during sexual arousal in healthy males (2002) (21)
p16INK4a expression and clinicopathologic parameters in renal cell carcinoma. (2007) (21)
Late results of bladder stimulation in 11 patients: followup to 4 years. (1978) (21)
Long-term follow-up after surgery for advanced colorectal carcinoma involving the urogenital tract. (2002) (21)
The impact of extracorporal circulation on therapy-related mortality and long-term survival of patients with renal cell cancer and intracaval neoplastic extension (2002) (21)
Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia (2010) (20)
Historical Aspects of the Treatment of Urinary Incontinence (2000) (19)
Max Brödel (1870-1941) and medical illustration in urology. (2000) (19)
Neurostimulation for lower urinary tract voiding problems (2000) (19)
Computer-assisted evaluation of the smooth-muscle electromyogram of the corpora cavernosa by fast Fourier transformation. (1997) (19)
Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parameters (2005) (19)
Petroleum jelly is an ideal contact medium for pain reduction and successful treatment with extracorporeal shock wave lithotripsy. (1999) (18)
[Endoscopic extraperitoneal radical prostatectomy. Results after 300 procedures]. (2004) (18)
Recent strategies for the use of paclitaxel in the treatment of urological malignancies (1998) (18)
Ileal conduit urinary diversion: Early and late results of 132 cases in a 25-year period (1985) (18)
Detection of low-molecular-mass plasma peptides in the cavernous and systemic blood of healthy men during penile flaccidity and rigidity--an experimental approach using the novel differential peptide display technology. (2002) (17)
Nikolaj A. Bogoraz (1874-1952): pioneer of phalloplasty and penile implant surgery. (2003) (17)
New methods in the diagnosis of impotence: RigiScan® penile tumescence and rigidity monitoring and diagnostic papaverine hydrochloride injection (1987) (17)
Single potential analysis of cavernous electrical activity in spinal cord injury patients. (1994) (17)
Treatment of anejaculation with electroejaculation. (1992) (17)
Transurethral microwave thermotherapy for the treatment of BPH: still a challenger? (2006) (16)
Detection of p53 gene alteration in renal‐cell cancer by micropreparation techniques of tumor specimens (1995) (15)
Overexpression of the p53 oncoprotein in carcinoma in situ of the testis. (1994) (15)
The history of endocrine therapy of benign and malignant diseases of the prostate (2000) (15)
Late relapse after treatment for nonseminomatous testicular germ cell tumors according to a single center-based experience (2004) (15)
Alfuzosin: a clinically uroselective alpha1-blocker. (2002) (15)
Urodynamics in the anatomical work of Leonardo da Vinci (1452–1519) (1999) (15)
Detection of viral HPV 16 DNA in prostate cancer and benign prostatic hyperplasia by quantitative PCR-directed analysis (2000) (15)
Renal-cell carcinoma with intracaval neoplastic extension: stratification and surgical technique (2004) (15)
Expression and distribution of cyclic GMP-dependent protein kinase-1 isoforms in human penile erectile tissue. (2008) (15)
Impact of tumor size on the long-term survival of patients with early stage renal cell cancer (2005) (14)
Prospective diagnostic efficiency of biopsy washing DNA GSTP1 island hypermethylation for detection of adenocarcinoma of the prostate (2007) (14)
New Perspectives in Sacral Nerve Stimulation: For Control of Lower Urinary Tract Dysfunction (2002) (14)
[Guidelines for German urologists on diagnosis of benign prostate syndrome]. (2003) (13)
Orchitis following mumps vaccination in an adult. (1994) (13)
Immunohistochemical description of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human labia minora. (2007) (13)
Modulation of β‐catenin‐mediated TCF‐signalling in prostate cancer cell lines by wild‐type and mutant p53 (2007) (13)
Use of assisted reproductive techniques for treatment of ejaculatory disorders. (1996) (13)
Molecular biological characterization of phosphodiesterase 3A from human corpus cavernosum. (1999) (12)
Current and future trends in the oral pharmacotherapy of male erectile dysfunction (2003) (12)
SACRAL ELECTRICAL NERVE STIMULATION FOR TREATMENT OF SEVERE VOIDING DYSFUNCTION (1999) (12)
Potential future options in the pharmacotherapy of female sexual dysfunction (2006) (12)
Intracavernous application of SIN-I in rabbit and man: functional and toxicological results. (1993) (12)
Distribution and functional significance of phosphodiesterase isoenzymes in the human lower urinary tract (2005) (12)
Single potential analysis of cavernous electrical activity (2004) (11)
Extracorporeal shock wave therapy for delayed union of long bone fractures – preliminary results of a prospective cohort study (1999) (11)
Cytokines and tumor vaccination. (1996) (11)
Systemic and cavernous plasma levels of endothelin 1 in healthy males during different functional conditions of the penis (2000) (11)
Max Brödel (1870-1941) and Howard A. Kelly (1858-1943)--urogynecology and the birth of modern medical illustration. (1999) (11)
Surgical bladder preserving strategies in the treatment of muscle-invasive bladder cancer (2002) (11)
Surgical strategy in late-stage renal cell cancer with intracaval extension. (1998) (10)
Comparison of the effects of various spasmolytic drugs on isolated human and porcine detrusor smooth muscle. (1998) (10)
Preliminary report on the effect of the nitric oxide donor SIN-1 on human cavernous tissue in vivo (1991) (10)
Selective pharmacological manipulation of the smooth muscle tissue of the genitourinary tract: a glimpse into the future (1999) (10)
Functional tissue engineering of autologous tunica albuginea: a possible graft for Peyronie's disease surgery. (2003) (10)
Endogenous vasoactive peptides and the human vagina--a molecular biology and functional study. (2011) (10)
Significant obliteration of the urethral lumen after Wallstent implantation. (1992) (10)
Interstitial cell tumor of testis: a delicate problem. (1979) (10)
The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumors (2004) (10)
In vitro viability of human cavernosal endothelial and fibroblastic cells after exposure to papaverine/phentolamine and prostaglandin E1 (2005) (9)
[Guidelines of German urologists on therapy of benign prostate syndrome]. (2003) (9)
EDITORIAL: AFTER THE GOLD RUSH-ADVANCING RESEARCH BASED CARE FOR PATIENTS WITH ERECTILE DYSFUNCTION (1998) (9)
Single potential analysis of cavernous electric activity —a possible diagnosis of autonomic impotence? (1990) (9)
Cytotoxicity of different intracavernous vasoactive drugs on cultured endothelial cells of human corpus cavernosum penis. (2004) (9)
Some historical reflections on the ageing male (2002) (9)
Evaluating the role of the serotoninergic system in the control of human seminal vesicle smooth muscle-an in vitro approach. (2009) (9)
Detection of p53 tumor-suppressor-gene protein in bladder tumors and prostate cancer: possible clinical implications (2004) (9)
[Biological vascularized matrix (BioVaM): a new method for solving the perfusion problems in tissue engineering]. (2004) (9)
63 Immunohistochemical presence of phosphodiesterase 11A in the human prostate (2004) (9)
Immunohistochemical presence of cyclic AMP- and cyclic GMP- phosphodiesterase isoenzymes in human clitoris (2003) (9)
Corpus cavernosum electromyography: technique and clinical implications. (1997) (9)
Medical students' exposure to urology in European schools: the European Association of Urology proposals for a convergence programme. (2010) (9)
The influence of anterior root stimulation (S2) in deafferented spinal cord injury men on cavernous electrical activity. (1992) (9)
Growth hormone, somatomedins and men's health (2002) (9)
Oestrogen in the Treatment of Prostatic Carcinoma (1989) (8)
Complete spontaneous regression in metastatic renal cell carcinoma — an update and review (1991) (8)
Prostate-specific antigen density — a reliable parameter for the detection of prostate cancer? (2004) (8)
Systemic and cavernosal plasma levels of endothelin (1-21) during different penile conditions in healthy males and patients with erectile dysfunction. (2001) (8)
822: Endoscopic Extraperitoneal Radical Prostatectomy (EERPE) - Experience After 300 Cases (2004) (8)
1318: Immunocytochemical Distribution of Nitric Oxide Synthases in the Human Prostate (2004) (8)
Systemic and cavernous plasma levels of endothelin (1-21) during different penile conditions in healthy males and patients with erectile dysfunction. (2001) (8)
Sacral electrical neuromodulation as an alternative treatment option for lower urinary tract dysfunction. (1999) (8)
[Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder]. (1995) (8)
Effects of magnesium citrate and phytin on reducing urinary calcium excretion in rats (2004) (8)
Comment on: Results of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction : Outcomes of a Prospective, Worldwide Clinical Study. Authors' reply (2008) (7)
Urodynamics and transurethral microwave thermotherapy (1998) (7)
FlexGuardTM: a new laser insertion sheath: functional aspects in ureterorenoscopy (URS) (2007) (7)
The portrait of James Israel by the German impressionist Max Liebermann: a selected pictorial view on the early twentieth century development of surgical urology in Berlin (2001) (7)
Curriculum in Urology Urodynamics Including Incontinence and BPH (1998) (7)
Telemetric urodynamic investigations in female incontinence. (1981) (7)
Werner Forssmann: surgeon, urologist, and Nobel Prize winner (1999) (7)
Prognostic value of p27Kip1 and p21WAF/Cip protein expression in muscle invasive bladder cancer. (1999) (7)
Transurethral bladder neck operation in neurogenic bladder. (1978) (7)
The determination of relative kidney function in obstructive uropathy with 99Tcm-DMSA. (1987) (7)
Immunohistochemical distribution of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human vagina: a potential forensic value? (2007) (7)
Transurethral microwave thermotherapy and laser treatment (1997) (7)
Functional electromyostimulation of the corpus cavernosum penis — preliminary results of a novel therapeutic option for erectile dysfunction (2004) (7)
Research methodology in urinary incontinence (1999) (6)
Editorial: Symptom Scores, Watchful Waiting and Prostate Specific Antigen Levels in Benign Prostatic Hyperplasia (1996) (6)
Single potential analysis of cavernous electrical activity (SPACE). Experiences, limitations and perspectives. (1993) (6)
Die Diagnose neurogen-autonom bedingter Erektionsstörungen: Single Potential Analysis of Cavernous Electric Activity (SPACE) (1990) (6)
Neurogenic Voiding Dysfunctions (NVD) (2003) (6)
66 Effects of phosphodiesterase inhibitors and nitric oxide donors on cultured human prostatic smooth muscle cells (2004) (6)
[The prevalence of sexual problems in female medical students]. (2004) (6)
Oestrogen in the treatment of prostatic carcinoma. What is the safe and effective dose of ethinyloestradiol? (1989) (6)
Spontaneous regression of metastatic renal carcinoma with long-term survival. (1991) (6)
[Regenerative medicine in andrology: tissue engineering and gene therapy as potential treatment options for penile deformations and erectile dysfunction]. (2004) (6)
[Functional electromyostimulation of the penile corpus cavernosum (FEMCC)]. Initial results of a new therapeutic option of erectile dysfunction]. (1996) (6)
[The modular image analysis computer for assessment of prognosis in testicular tumors]. (1990) (6)
508 New antimuscarinic agent, solifenacin succinate, reduces urgency episodes in overactive bladder: An analysis of over 3000 patients (2004) (6)
Results following Prostatectomy (1978) (6)
IMMUNOCYTOCHEMICAL DISTRIBUTION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE (eNOS) IN HUMAN CORPUS CAVERNOSUM (1999) (5)
A New Concept of Urodynamic Evaluation of the Lower Urinary Tract (1978) (5)
The chip camera: perfect imaging in endourology (1988) (5)
The renal paracrine peptide system — possible urologic implications of urodilatin (1996) (5)
[Thermotherapy of benign prostatic hyperplasia]. (1995) (5)
Computer-assisted interpretation of electromyograms of corpora cavernosa using fuzzy logic (2005) (5)
Systemic and cavernous plasma levels of vasopressin in healthy males during different functional conditions of the penis (2003) (5)
[Positron emission tomography (PET) for diagnosis and monitoring of treatment for urological tumors]. (2004) (5)
Do We Need Bone Anchors in Urogynecology? (1999) (5)
[Pharmacological therapy in erectile dysfunction--current standards and new viewpoint]. (1997) (5)
Five years' experience with the Silicone-Silver Penile Prosthesis: Improvements and new developments (1983) (5)
for the recurrence-free and long-term survival of prostate cancer patients (1999) (4)
Johannes Scultetus (1595–1645) (1998) (4)
45 CONTRACTION-RELAXATION STUDIES ON ISOLATED HUMAN PROSTATE TISSUE: THE ROLE OF ENDOTHELIN 1, PHOSPHODIESTERASE INHIBITORS, AND CYCLIC NUCLEOTIDES (2007) (4)
P53 regulated maspin protein expression determines recurrence-free survival of patients with localised prostate cancer (2000) (4)
Introduction and Conclusions (2005) (4)
Prognostic value of intracaval neoplastic extension for patients with renal cell cancer (1998) (4)
Analysis of the cyclin-dependent kinase inhibitor p27Kip1 in muscle invasive bladder cancer. (1999) (4)
[Inguinovaginal sling operation in the treatment of female urinary incontinence (author's transl)]. (1978) (4)
Overactive Bladder: What Matters to the Patient? (2007) (4)
Comparison of Human Normal Renal Cells and Malignant Renal Cells In Vivo and In Vitro Using Cytological, Cytochemical, and Immunocytochemical Methods (1989) (4)
SMOOTH MUSCLE ELECROMYOGRAPHY (2001) (4)
Strategies in the oral pharmacotherapy of male erectile dysfunction viewed from bench and bedside (Part II) (2005) (4)
Which Anatomical Structures in Fact Achieve Urinary Continence (1978) (4)
1246: Lasting Improvement is Demonstrated in Patients with Voiding Disorders Treated with Sacral Nerve Stimulation (2004) (4)
SEXUAL MEDICINE HISTORY: Early Photo-Illustration of a Hermaphrodite by the French Photographer and Artist Nadar in 1860 (2006) (4)
885: Prevalence of Female Sexual Dysfunction in Germany (2004) (4)
Smooth muscle electromyography. (2001) (4)
The principles and clinical application of advanced urodynamic analysis for BPH. (1994) (4)
Histochemical distribution of phosphodiesterase isoenzymes 3, 4 and 5 in the human prostate (2003) (4)
Urodynamic evaluation of the lower urinary tract (1979) (3)
239 In vitro effect of different intracavernous vasoactive drugs on the vaibility of human cavernosal endothelial cells (2004) (3)
Rabbit penile corpus cavernosum: electrical and mechanical activity of isolated strips. (1994) (3)
The expression of renal antigens in renal cell carcinoma (1984) (3)
Differential diagnosis in erectile impotence. Intracorporeal papaverine injection and RigiScan tumescence and rigidity monitoring. (1988) (3)
Prostate-specific antigen—comparative clinical appreciation of a serodiagnostic measure after 8 years of experience (1989) (3)
Proliferative behaviour and cytogenetic changes in human renal-cell carcinoma (1991) (3)
[In vitro effects of cAMP- and cGMP-stimulating drugs on the relaxation of the prostate smooth muscle tissue contraction induced by endothelin-1]. (2006) (3)
[Prognostic relevance of vena cava thrombosis in renal cell carcinoma]. (1998) (3)
Bilateral metachronous testicular germ cell tumors occurring in two non-twin brothers. Case report and review of the literature. (1995) (3)
Intracavernous pharmacotherapy (2005) (3)
[Automated uroflowmetry: new variables]. (1986) (3)
Urodynamic equipment for screening and office use: CO2 cystometry. (1977) (3)
In vitro sensitivity testing of human renal cell carcinoma with cytostatic agents and interferon alpha-2a (2004) (3)
[Pharmacological therapy of erectile dysfunction]. (1998) (3)
Symptom scores, watchful waiting and prostate specific antigen levels in benign prostatic hyperplasia. (1996) (3)
[Vasectomy: minor intervention--grave sequelae]. (1992) (3)
The great debate resolved: The urethral closure pressure profile should be used for diagnosis and management of female stress incontinence (1983) (3)
[Silicone-silver penis prosthesis (Jonas-Eska), long-term experiences. A critical assessment]. (1991) (3)
In vitro effects of a novel class of no donating compounds on isolated human erectile tissue (2002) (3)
A new therapeutic concept for long-lasting iatrogenic priapism: a case report. (1992) (3)
Heterogeneous p27Kip1 Expression within Primary Renal Cell Cancers, Their Invasive Margins and Peritumoral Renal Parenchyma Correlation with Pathological and Prognostic Features (2007) (2)
[ESWL in hemophilia B]. (1992) (2)
Late relapse of testicular cancer presenting as differentiated teratoma - report of a case and discussion of the clinical implications. (1995) (2)
Alloplastics in the Treatment of Erectile Dysfunction (1991) (2)
Interstitial Brachytherapy (LDR-Brachytherapy) in the Treatment of Patients with Prostate Cancer (2006) (2)
216 DISTRIBUTION OF CYCLIC AMP-DEPENDENT PROTEIN KINASE-1 ISOFORMS IN HUMAN CAVERNOUS ARTERIES AND CORPUS CAVERNOSUM: RELATION TO VASOACTIVE INTESTINAL POLYPEPTIDE-CONTAINING NERVES AND PDE4 (2007) (2)
Erectile Dysfunction and Anejaculation (2000) (2)
The need for microdissectional tumor cell preparation during the molecular genetic analysis of prostate cancer (1999) (2)
[Johann Friedrich Dieffenbach (1792-1847) as the founder of plastic surgery. His contribution to maxillofacial surgery]. (1998) (2)
Local and distributed effects of apomorphine on cortical activity in men with erectile dysfunction (2002) (2)
SINGLE CENTRE LONG TERM RESULTS OF INTERNAL URETHROTOMY IN 924 MALE PATIENTS (2008) (2)
Magnetic resonance imaging of the bladder and prostate (1985) (2)
1072: Mechanisms of Action of Human Growth Hormone(GH) on Isolated Human Penile Erectile Tissue (2005) (2)
Experimental considerations and clinical application of electrostimulation for bladder evacuation. (1979) (2)
Plasma levels of cyclic guanosine-3′,5′-monophosphate in the cavernous and systemic blood of healthy males during different functional conditions of the penis (2001) (2)
Intracavernous Application of SIN-1 in Rabbit and Man (1993) (2)
[Spontaneous ruptures of the urinary bladder in the routine forensic examination]. (2006) (2)
RELAXATION OF HUMAN DETRUSOR SMOOTH MUSCLE IN VITRO BY MODULATION OF CYCLIC NUCLEOTIDE DEPENDENT PATHWAYS (1999) (2)
[Medical therapy of urinary incontinence]. (2004) (2)
Evaluation of urodynamic studies by computer (2004) (2)
General anesthesia for ureteral measurements in the rabbit. (1996) (2)
686: Impact of Previous Surgery on Endoscopic (Laparoscopic) Extraperitoneal Radical Prostatectomy (EERPE) (2005) (2)
Re: Multiple fractures of the silver wire strands as a complication of the silicone-silver wire prosthesis. (1985) (2)
[Metastatic adult teratoma of the testis. Possibilities of chemotherapy and surgical treatment]. (1994) (2)
Johannes Scultetus (1595-1645). Urologic aspects in the 'Armamentarium chirurgicum'. (1998) (2)
[alpha 1-receptor blockade in therapy of benign prostatic hyperplasia syndrome. Correct dosing for optimal effectiveness]. (2002) (2)
[Impact of tumor size on long-term survival of patients with organ-confined renal cell cancer]. (2003) (2)
[Dorsal ligation of the penile vein--prognostic factors and long-term outcome]. (1997) (2)
Efficient pathway for early detection of prostate cancer concluded from a 5-year prospective study (2004) (2)
Pyelovenous backflow or veno-caliceal valve fistula? (2007) (2)
Comparative study of the urinary tract pressure recording, using three different techniques. An experimental study and its clinical analysis. (1978) (2)
Systemic and cavernous plasma levels of endothelin (1–21) during different penile conditions in healthy males and patients with erectile dysfunction (2001) (2)
Overview of the West German Urological Multicenter Study Traumatology (1990) (2)
248 Detection of phosphodiesterase isoenzymes 1, 2, 10 and 11 in the human clitoris by means of molecular biology and immunohistochemistry (2004) (2)
PRIAPUS — non-contact monitoring of penile dimension changes by photogrammetry (2005) (2)
Trends in future urodynamics: computer support-data base-digitized imaging. (1991) (2)
Laparoscopic Localization of the Impalpable Testis (1987) (1)
Application of factor analysis for the determination of specific frequency bands in corpus cavernosum EMG power density spectra (2004) (1)
Early photo-illustration of a hermaphrodite by the French photographer and artist Nadar in 1860. (2005) (1)
Immunohistochemical detection of cathepsin-d expression in prostate-cancer. (1994) (1)
Erratum to Evaluating the Role of the Serotoninergic System in the Control of Human Seminal Vesicle Smooth Muscle An In Vitro Approach [The Journal of Sexual Medicine, (2009), 6, 2672 9) (2010) (1)
Intratesticular self-injection of testgasoline. (2000) (1)
TUR Using the Spoonloop Resectoscope (1988) (1)
EXPRESSION OF PHOSPHODIESTERASE (PDE) ISOENZYMES IN THE HUMAN SEMINAL VESICLE (SV) AND EFFECTS OF PDE INHIBITORS ON THE CONTRACTILE RESPONSES OF ISOLATED HUMAN SEMINAL VESICLE SMOOTH MUSCLE (2008) (1)
Cyclic AMP- and cyclic GMP-binding protein kinases in the human vagina: Expression and co-localization with eNOS, VIP and PGP 9.5 (2008) (1)
Loss of maspin expression in prostate cancer induced by a P53- and HER-2- pathway/overexpression profiling by whole-mount derived tissue microarrays (2003) (1)
336 EFFECTS OF PHOSPHODIESTERASE TYPE 5 INHIBITORS ON THE ENDOTHELIUM-DEPENDENT RELAXATION OF ISOLATED HUMAN VAGINAL ARTERIES (2007) (1)
Bladder dysfunction, gynaecological aspects of urology (1992) (1)
Miac a modular image analysis computer for automated cytology (1987) (1)
Localized renal-cell carcinoma: detection of abnormal cells in peritumoral tissue (1995) (1)
Magnetic resonance imaging in the diagnosis and staging of renal masses: a critical appraisal and comparison with computed tomography (1988) (1)
[Urodynamics of normal and disordered miction]. (1979) (1)
Evolutions in Urodynamics: Multidisciplinary Treatment of GU Tumors with Emphasis on Immuno- and/or Chemotherapy 2nd Urological Research Forum, Okinawa, January 1990 (1991) (1)
FURTHER EVIDENCE FOR A FUNCTIONAL ROLE OF cAMP IN THE REGULATION OF HUMAN CAVERNOUS SMOOTH MUSCLE TONE IN VITRO (1999) (1)
The bifocal multiplane transrectal transducer: a valuable adjunct to physical and immunochemical findings for early detection of prostate cancer (1988) (1)
330 PHOSPHODIESTERASE INHIBITORS ATTENUATE THE CONTRACTILE ACTIVITY OF HUMAN SEMINAL VESICLE SMOOTH MUSCLE -AN IN VITRO STUDY (2007) (1)
Borderline surgery of invasive kidney tumours (1984) (1)
[Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status]. (1996) (1)
178 FIRST EXPERIENCE ON THE AUTOMATIC EVALUATION OF UROFLOW MEASUREMENTS WITH UROFLOWMETER “UROPOWER” (2007) (1)
Entering data into expert system for lower urinary tract pressure-flow studies. (1991) (1)
Transplantation and Erectile Dysfunction (1992) (1)
Phosphodiesterase activity in human ureter and the effect of various selective inhibitors (1993) (1)
[Diagnosis and therapy of renal echinococcosis]. (1991) (1)
The need for routine adrenalectomy during the surgical treatment of renal cell cancer - the Hannover experience (2002) (1)
Penile venous surgery – prognostic factors and long-term results (1997) (1)
861 Use of bone marrow derived mesenchymal stem cells for autologous tissue engineering of urinary bladder muscularis (2004) (1)
The effect of the inhibition of the nitric oxide synthase by NG-nitro-L-arginine on the erection of the rabbit. (1994) (1)
Current clinical relevance of immunotherapy in metastatic renal cell cancer (1991) (1)
DECREASED P27KIP PROTEIN EXPRESSION AS DETERMINED BY TISSUE MICROARRAY ANALYSIS (TMA) PREDICTS THE CLINICAL PROGNOSIS OF RENAL CELL CANCER PATIENTS (2006) (1)
Bladder dysfunction, gynaecological aspects of urology Editorial overview (1993) (1)
[Differentiated teratoma as late recurrence of metastatic non-seminomatous testicular germ cell tumor. Case report and clinical problems]. (1995) (1)
320 Endoscopic extra peritoneal radical prostatectomy (EERPE) - experience after 300 procedures (2004) (1)
Effects of Potassium Channel Modulators on Human Detrusor Smooth Muscle Myogenic Phasic Contractile Activity: Potential Therapeutic Targets for Overactive Bladder (2007) (1)
1445: Effects of Drugs Interfering with the CGMP-pathway on the Tension Induced by Endothelin-1 of Isolated Human Prostate Tissue (2005) (1)
The Prognostic Role of Alterations of the p53 Tumor Suppressor Gene in Superficial and Advanced Stage Bladder Cancer (1995) (1)
[Crushing of kidney stones: tomorrow's reality? (noninvasive lithotripsy by shock waves)]. (1983) (1)
1336: Immunohistochemicalpresence of Phosphodiesterase (PDE)11A in the Human Prostate (2004) (1)
Automated DNA-image cytometry: a prognostic tool in infiltrating bladder carcinoma? (1987) (1)
NITRIC OXIDE DONORS REVERSE THE TENSION INDUCED BY ENDOTHELIN-1 OF ISOLATED HUMAN PROSTATE TISSUE AND STIMULATE THE PRODUCTION OF CYCLIC GMP (2006) (1)
Results of the automated analysis of 328 bladder specimens using the Leyden television analysis system (LEYTAS) (1983) (1)
Possible influence of human growth hormone in penile erection (2003) (0)
[Results of reconstructive surgery in renal hypertension]. (1976) (0)
[Vascular reconstruction of stenosis in the truncus celiacus region]. (1973) (0)
IN-VITRO-EFFECTS OF SEROTONIN REUPTAKE INHIBITORS ON HUMAN SEMINAL VESICLE AND ITS POTENTIAL ROLE IN THE EJACULATION PROCESS (2008) (0)
819 ATM VARIANT P1054R AND RISK OF RADIATION-INDUCED MORBIDITY AFTER PERMANENT INTERSTITIAL BRACHYTHERAPY (2007) (0)
494Mitotic catastrophe marker cyclin B1 in renal cell carcinoma correlates with stage, metastasis and survival of patients (2005) (0)
Subject Index Vol. 36, 1999 (1999) (0)
506Cyclic AMP-phosphodiesterase isoenzymes in the human labia minora — An immunohistochemical study (2005) (0)
Percutaneous bladder neck suspension with bone fixation. Surgical technique and first results in 26 patients (1998) (0)
New aspects on the identification of genetic alterations and prognostically important biological parameters in renal cell cancer (1999) (0)
[Erectile impotence. Diagnosis and therapy]. (1989) (0)
Surgical treatment of erectile impotence. (1983) (0)
[Conservative therapy of phosphate calculi]. (1984) (0)
Contents, Vol. 47, Supplement 1, 1991 (1991) (0)
Radical retropubic prostatectomy: Apical dissection without ligature of the dorsal plexus (2003) (0)
Internal Urethrotomy in Male Urethral Strictures (1988) (0)
500 Re-evaluation of the latest modification of the TNM-classification for T1 renal cell cancer by multivariate statistical analysis (2004) (0)
13 First treatment choices for LUTS/BPH: A study in 6 European countries (2005) (0)
Further experiences with the stereoresectoscope: description and clinical use. (1982) (0)
Alteration of thep53Tumor Suppressor Gene in Prostate Cancer: Analytical Approaches and Clinical Implications (1998) (0)
MP-12.05: Mechanisms of action of human growth hormone on isolated human penile erectile tissue (2007) (0)
415 ENDOSCOPIC EXTRAPERITOENAL RADICAL PROSTATECTOMY - ONCOLOGICAL AN FUNCTIONAL RESULTS OF THE FIRST 250 CONSECUTIVE PATIENTS (2007) (0)
236 Androgen and estrogen receptors in the human corpus cavernosum penis: Immunohistochemical and cell culture results (2004) (0)
[Fertility disorders following retroperitoneal lymphadenectomy]. (1971) (0)
Reduction of Cost of Dornier HM3 Treatment by Using Refurbished Electrodes (1991) (0)
Initial Clinical Experience with the Intracavernous Application of the Nitric Oxide Donor Sin 1 in the Treatment of Patients with Erectile Dysfunction (1995) (0)
147 WERNER FORSSMANN - 50 YEARS AFTER AWARDING THE NOBEL PRIZE OF MEDICINE (2007) (0)
1012: Quantitative Analysis of Hypermethylation of the Potential Tumor Suppressor Gene Rassf1A in Renal Cell Carcinoma and Correlation with Clinicopathological Factors (2004) (0)
[Modern urodynamics]. (1987) (0)
183 IN VITRO FUNCTIONAL RESPONSES OF ISOLATED HUMAN VAGINAL TISSUE TO VASOACTIVE ENDOGENOUS PEPTIDES AND THEIR INTERACTION WITH CYCLIC NUCLEOSIDE MONOPHOSPHATE PATHWAY (2010) (0)
Urological surgery, surgical techniques, technology (1997) (0)
The importance of biological characteristics for the prognosis of renal cell carcinoma (1991) (0)
654: Mitotic Catastrophe Marker Cyclin B1 in Renal Cell Carcinoma Correlates with Stage Metastasis and Survival of Patients (2005) (0)
Subject Index Vol. 55, 1995 (1995) (0)
457 Analysis of oncogenic human papillomaviruses in the male urogenital system and detection of viral DNA in prostate cancer and seminal vesicle specimens (2004) (0)
[Obstructive uropathy of the lower tract and incidence of vesico-renal reflux]. (1977) (0)
Contents, Vol. 19, Supplement 1, 1979 (1979) (0)
Reseeded vascularized biological scaffold with arterial and venous pedicles for bladder substitution (2003) (0)
Reduced Expression of the Cell Cycle Regulator p27Kip1 within the Invasion Front of Renal Cell Carcinomas Proved to be a Significant Marker for Disease-specific Survival. (2006) (0)
CHARACTERISATION OF VARIOUS DRUGS LIKELY TO PLAY A ROLE IN HUMAN SEMINAL VESICLE CONTRACTILITY (2008) (0)
CORRELATION OF P16INK4 EXPRESSION IN RENAL CELL CARCINOMA WITH CLINICOPATHOLOGICAL PARAMETERS (2006) (0)
Development of a PC-based expert system for lower urinary tract pressure-flow studies (1990) (0)
13-CIS-RETINOIC ACID LEADS TO IMPROVED SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (1999) (0)
THE PREDICTIVE VALUE OF PRESSURE FLOW STUDY FOR THE SYMPTOMATIC OUTCOME OF TURP (1999) (0)
Therapy for kidney cell carcinoma with cava thrombus. Importancy of extracorporeal circulation and prognostic value of cranial tumor extension (1999) (0)
[Conservative-surgical therapy of the neurogenic bladder]. (1978) (0)
[Bladder catheterization in non-urologic patients. Indications, risks and preventive measurements]. (1979) (0)
Editorial: Renal cell carcinoma (1995) (0)
CORRELATION OF RAS ASSOCIATION FAMILY 1A GENE EXPRESSION IN RENAL CELL CARCINOMA WITH PATHOLOGICAL PARAMETERS AND SURVIVAL OF PATIENTS (2006) (0)
[Control mechanisms of tonus of smooth muscle of the prostate and their potential significance for pharmacotherapy of benign prostatic syndrome]. (2007) (0)
1622: Detection of Phosphodiesterase (Pde)Isoenzymes 1, 2, 10 and 11 In The Human Clitoris By Means of Molecular Biology and Immunohistochemistry (2004) (0)
Additional Literature on ESWT of the Musculoskeletal System (2001) (0)
151Functional responses of isolated human prostate tissue to drugs interfering with the cgmp-pathway (2005) (0)
QUANTITATIVE ANALYSIS OF RAS ASSOCIATION FAMILY 1A GENE (RASSF1A) PROMOTER METHYLATION IN RENAL CELL CARCINOMA, PERITUMOURAL AND NORMAL RENAL PARENCHYMA (2006) (0)
IIC-acetate positron emission tomography in prostate cancer patients (2003) (0)
495Invade or proliferate? A comparative analysis of expression of cell cycle regulators in invasive margin and primary tumour tissue in renal cell cancer (2005) (0)
[Modulith SL 20. One-year urologic experience with a lithotripter of the third generation]. (1994) (0)
In Vitro Determination of Optimal Conditions for Coagulum Pyelolithotomy (1985) (0)
1523: GA-68-Dotabom-Pet for the Detection of Prostate Cancer (2005) (0)
Expression of cyclic AMP-dependent protein KINASE-I isoforms in the human prostate: Relation to smooth muscle alpha-actin and PDE4 (2008) (0)
[Evaluation of blood and breath alcohol measurement in patients with hepatocellular carcinoma during procedures in intubated patients with percutaneous ethanol instillation]. (2007) (0)
1445: Immunohistochemical Presence of Cyclic AMP and Cyclic GMP-Dependent Protein Kinases A and G in Human Corpus Cavernosum Andcavernous ARTERIES (2004) (0)
Storage-phosphor digital radiography in genitourinary radiology (1990) (0)
Clinical Relevance of Proliferation Rates in Renal Cell Carcinoma (1992) (0)
A QUESTIONNAIRE - BASED OUTCOME ANALYSIS OF STAMEY BLADDER NECK SUSPENSION PROCEDURE (1999) (0)
Ergebnisse nach sekundärer Lymphadenektomie (1988) (0)
707 Quantitative analysis of hypermethylation of the potential tumour suppressor gene rassf1A in renal cell carcinoma and correlation with clinicopathological factors (2004) (0)
[Detection of hypermethylated gene promotors in diagnosis of prostate cancer]. (2007) (0)
Seminoma clinical stage i standard therapy still acceptable (1990) (0)
UP-01.09: The glucose metabolism in clear cell and papillary renal cell carcinomas - A structural analysis of components (2006) (0)
FUNCTIONAL SIGNIFICANCE OF cAMP-DEPENDENT PROTEIN KINASE A IN THE REGULATION OF SMOOTH MUSCLE TONE IN THE HUMAN PROSTATE (2008) (0)
511Primary cell cultures of the human corpus cavernosum: Isolation, cultivation and purification for basic research and tissue engineering (2005) (0)
LAPAROSCOPY IN GERMAN UROLOGY – THE UPCOMING STANDARD FOR SEVERAL INDICATIONS (2008) (0)
Subject Index Vol. 39, 2001 (2001) (0)
616: Denaturation of Urinary Nucleases Prior to Isolation of DNA Improves PCR Analyses from Urine (2005) (0)
Predictive value of different parameters for stricture recurrence after internal urethrotomy (2003) (0)
Applicability of Serological Markers (1991) (0)
107: Analysis of Oncogenic Human Papilloma Viruses in the Male Urogenital System and Detection of Viral DNA in Prostate Cancer and Seminal Vesicle Specimens (2004) (0)
652: Invade or Proliferate? A Comparative Analysis of Expression of Cell Cycle Regulators in Invasive Margin and Primary Tumor Tissue in Renal Cell Cancer (2005) (0)
Endourology: New and Approved Techniques (1988) (0)
Abstracts of the 11th Annual Meeting of the German Society of Andrology (1999) (0)
Phase II Study of Mafosfamide in Progressive Advanced Renal Cell Carcinoma (1989) (0)
1418: Do Intravacernous Vasoactive Drugs Influence Endothelial Cell Integrity of the Human Corpus Cavernosum? A Cell Culture Study (2004) (0)
1210: The Nitric Oxide I Cyclic GMP- & Rho-Kinase-Pathways Regulate Tonus of Isolated Subepithelial Human Vaginal Arteries (2006) (0)
395: Decreased P27KIP Protein Expression as Determined by Tissue Microarray Analysis (TMA) Predicts the Clinical Prognosis of Renal Cell Cancer Patients (2006) (0)
Male stress incontinence. Diagnostic work-up and therapteutic considerations. (1980) (0)
678: Expression of Cyclic AMP-Dependent Protein Kinase-1 Isoforms in Human Penile Erectile Tissue: Relation to Vasoactive Intestinal Polypeptide-Containing Nerves and PDE4 (2007) (0)
LONG-TERM FOLLOWUP OF PATIENTS WITH RETROPERITONEAL FIBROSIS (1999) (0)
Low frequence of alterations at the P27 Kip1 gene locus in localized prostate cancer (2002) (0)
RigiScan Penile Rigidity and Tumescence Monitoring in Impotent Patients as a Diagnostic Tool and as an Objective Assessment of the Effect of Intracorporeal Injection of Papaverine Hydrochloride (1987) (0)
[Recent results in urodynamics]. (1979) (0)
4Adrenalectomy is a curative treatment option for renal cell cancer patients with solitary intraadrenal metastatic spread (2005) (0)
The reliability of Tc-99m-DMSA scintigraphy in obstructive uropathy: is late scanning at 24 hours necessary? (1986) (0)
423 DOWN-REGULATION OF β-CATENIN-MEDIATED T-CELL FACTOR-SIGNALING IN PROSTATE CANCER CELL LINES BY P53 (2007) (0)
417: Expression of Phosphodiesterase (PDE) Isoenzvmes 1, 4 and 5 in the Human Detrusor - An Immunohistochemical Study (2007) (0)
After the gold rush--advancing research based care for patients with erectile dysfunction. (1998) (0)
[Therapy of micturition disorders]. (2008) (0)
Study of three urethral pressure recording devices: Theoretical considerations (2004) (0)
Extracorporeal shock wave therapy for delayed union of long bone fractures-Preliminary results of a prospective cohort study (2000) (0)
Stress incontinence in females: which factors play a role in operative results? (1988) (0)
IS THERE A SIGNIFICANCE OF BETA-ENDORPHIN IN THE CONTROL OF THE MALE ERECTILE RESPONSE? (2008) (0)
A Successful Concept for Anesthesia in Extracorporeal Shock-Wave Lithotripsy (1989) (0)
SIGNIFICANCE OF THE NITRIC OXIDE (NO) PATHWAY IN THE CONTROL OF HUMAN VAGINAL TISSUE: A FUNCTIONAL AND IMMUNOHISTOCHEMICAL STUDY (2006) (0)
Stickoxid (NO) als möglicher Neurotransmitter in der Tonusregulation des Ureters (1995) (0)
p53 mutant gene expression in paraffin embedded and fresh frozen tissue of different urogenital tumors. (1994) (0)
THE TREATMENT OF MALDESCENSUS TESTIS IN THE MIRROR OF THE LAST CENTURIES (2008) (0)
[Therapy of irritable bladder and urinary incontinence]. (1981) (0)
[Benign prostatic hyperplasia syndrome--drugs instead of operation?]. (2002) (0)
324 Endoscopic extraperitoneal radical prostatectomy - Learning curve, pitfalls, troubleshooting: Experience with four surgeons (2004) (0)
Contents, Vol. 55, 1995 (1990) (0)
[Therapy of no stress-induced urinary incontinence]. (1979) (0)
Andropen — preset self-injection pen for intracavernous auto-injection therapy in erectile impotence (1990) (0)
[Percutaneous bladder neck suspension with osseous fixation. Surgical technique and initial results in 26 patients]. (1998) (0)
42: Adrenalectomy is a Curative Treatment Option for Renal Cell Cancer Patients with Solitary Intraadrenal Metastatic Spread (2005) (0)
Detrusor-regeneration in an acellular bladder matrix graft on a rat bladder: does exogenous EGF-administration have an impact (2002) (0)
1346: In Vitro Effects of a Novel Class of Compounds Interfering With the CGMP-Pathway on Isolated Human Prostate Tissue (2004) (0)
339 IN VITRO EFFECTS OF TESTOSTERONE AND DIHYDROTESTOSTERONE ON CYCLIC AMP AND CYCLIC GMP LEVELS IN ISOLATED HUMAN CAVERNOUS ARTERIES AND CORPUS CAVERNOSUM (2007) (0)
Experiences with ESWL-Dornier HM-3-Modulith® (1990) (0)
114 High prevalence of sexual dysfunction among young women (2004) (0)
Medical treatment of erectile dysfunction. Current status and prospects (1999) (0)
Registration of Cavernous Electrical Activity and its Interpretation (1991) (0)
Proceedings of the 5th WHO International Consultation on BPH (2000) (0)
Significant Obliteration of the Lumen after Wallstent Implantation (1992) (0)
Promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in ear (2011) (0)
Pharmacotherapy for detrusor instability and symptoms of the overactive bladder (2001) (0)
Coagulum pyelolithotomy: the determination of optimal conditions for clot formation (1986) (0)
Analytical cytology: its role in urological oncology. (1984) (0)
[Leydig-cell tumor. Postoperative study of 9 cases during 7 years]. (1976) (0)
THE PREDICTION OF CLINICAL OUTCOME FROM TRANSURETHRAL EUROPEAN MULTICENTER STUDY MICROWAVE THERMOTHERAPY BY PRESSURE-FLOW ANALYSIS: A (1995) (0)
MAX BRODEL AND MODERN MEDICAL ILLUSTRATION (1999) (0)
ANDROGENS REGULATE SMOOTH MUSCLE CONTRACTILITY OF HUMAN CAVERNOUS ARTERIES AND CORPUS CAVERNOSUM BY NON-GENOMIC MECHANISMS (2006) (0)
Male Stress Incontinence (1980) (0)
729Retrospective quantitative analysis of GSTP1 promotor hypermethylation in sera of patients with cancer and benign hyperplasia of the prostate (2005) (0)
Identification of the biological aggressiveness of renal cell cancer by a “multiparameter” model (2002) (0)
Acellular tissue matrix as a biomaterial for vaginal reconstruction - a pilot study in rats (2002) (0)
Clinical Evaluation of Uroflow Diagnostic Interpretation (UDI) Software (1987) (0)
Limitations of tissue microarrays in the evaluation of bcl-2 and P53 expression in whole mount derived prostate tissues (2003) (0)
EXPRESSION OF CYCLIC AMP AND CYCLIC GMP RECEPTOR PROTEINS IN THE HUMAN VAGINA – COLOCALIZATION WITH ENOS, VIP AND PGP9 (2008) (0)
Detrusor-regeneration in an acellular bladder matrix graft on a rat bladder The impact of EGF-administration (2001) (0)
The development of modern sexology in Berlin before 1933 (2002) (0)
997: Correlation between the Tumor Size and the Biological Aggressiveness of Renal Cell Cancers Classified as T1 Disease (2005) (0)
[Causes and therapy of postoperative retention of urine]. (1979) (0)
Letter to the Editor. Re: single potential analysis of cavernous electrical activity in spinal cord injury patients. (1994) (0)
[Light-and electronmicroscopic studies of lymphnode after immunisation]. (1972) (0)
IN VITRO FUNCTIONAL RESPONSES OF ISOLATED HUMAN PROSTATE TISSUE TO ARGINASE INHIBITORS (2008) (0)
The penoscrotal sphincter to treat male sphincter insufficiency (1986) (0)
CYCLIC AMP- AND CYCLIC GMP-BINDING PROTEIN KINASES IN HUMAN THE VAGINA – EXPRESSION AND CO LOCALISATION WITH ENOS, VIP AND PGP (2008) (0)
Subcutaneous implantation of the bladder acellular matrix graft: a pilot study (2002) (0)
Is superficial bladder cancer mococlonal or polyclonal in origin (2003) (0)
Contents, Vol. 35, 1980 (1980) (0)
Altered P27 KIP1 expression predicts long-term survival of patients with renal cell cancer as demonstrated by tissue microarray analysis (2003) (0)
445Does previous surgery has an impact on endoscopic (laparoscopic) extraperitoneal radical prostatectomy (2005) (0)
BPS - Medikamente statt Operation? (2002) (0)
Cavomat semi automatic intracavernous injection pump (1990) (0)
LONG-TERM ERECTILE FUNCTION AFTER LDR-BRACHYTHERAPY WITH IODINE-125 FOR THE TREATMENT OF LOCALISED PROSTATE CANCERS (2006) (0)
445: Early Onset and Age-Related Accumulation of the RAS Association Domain Family 1A Promoter Methylation in Normal Kidney Tissue Together with Heterogeneous Loss of Expression Indicate a Role in Tumorigenesis of Renal Cell Cancer (2007) (0)
[Consumption coagulopathy in obstructive septic pyelonephritis]. (1973) (0)
DISTRIBUTION OF RHO-KINASE-RELATED PROTEINS AND EFFECTS OF Y27632 IN HUMAN CAVERNOUS ARTERIES (2006) (0)
Contents, Vol. 32, 1977 (1977) (0)
[Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia]. (1998) (0)
Long-term outcome of cytoreductive surgery for recurrent renal cell carcinoma (2002) (0)
POS-02.44: Further evidence for a significance of the nitric oxide (NO) cyclic gmp signalling in the control of the human prostate (2007) (0)
235 Immunohistochemical presence of cyclic adenosin monophosphate and cyclic guanosine monophosphate phosphodiesterase isoenzymes in the human vagina (2004) (0)
Pharmacotherapy of erectile dysfunction (1998) (0)
Contents Vol. 39, 2001 (2001) (0)
186Correlation between the tumour size and the biological aggressiveness of renal cell cancers classified as T1 disease (2005) (0)
575 LOSS OF UROCORTIN I PEPTIDE EXPRESSION IN RENAL CELL CARCINOMA SUGGESTS CORTICOTROPIN RELEASING FACTOR RECEPTOR 2 ACTIVATION AS NEW THERAPEUTIC TARGET FOR ANTI-ANGIOGENESIS (2007) (0)
16 Cigarette smoking as a risk factor in penile corpus cavernosum degeneration (2004) (0)
Concepts of the physiology of erection in the 16th and 17th century (2003) (0)
POD-05.06: The peripheral role of serotonin reuptake inhibitors on the human seminal vesicle: in vitro study (2007) (0)
[Urodynamic studies are standard in today's diagnosis]. (1982) (0)
47 TISSUE DISTRIBUTION OF UROCORTIN I, ITS RELATED PEPTIDES AND CORTICOTROPHIN RELEASING FACTOR RECEPTOR 2 IN THE HUMAN PROSTATE AND THEIR POSSIBLE ROLE IN THE PATHOPHYSIOLOGY OF BPH (2007) (0)
POS-02.140: Spontaneous rupture of the urinary bladder as a cause of death (2007) (0)
[Cytostatic therapy of tumors under conditions of partial synchronisation with particular reference to malignant tumors of the testicle (author's transl)]. (1975) (0)
New aspects on the treatment and prognosis of penile cancer (2003) (0)
[Is adrenalectomy an indispensable part of nephrectomy? Results of a multivariate statistical analysis]. (2003) (0)
Perfusionof Tumor-BearingKidneys as a Model for ScintigraphicScreening of MonoclonalAntibodies (2006) (0)
234 Immunohistochemical presence of cyclic AMP and cyclic GMP-dependent protein kinase A and G in human cavernous arteries and corpus cavernosum (2004) (0)
432: Treatment of Late Relapse of Non-Seminomatous Testicular Germ Cell Tumors (2005) (0)
[Iatrogenic micturition disorders--urodynamic measurement and therapeutic consequences]. (1979) (0)
Immunohistochemical Localisation of ADCP: A Potential Prognostic Marker in Pro Static Cancer (1987) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Udo Jonas?

Udo Jonas is affiliated with the following schools:

Hannover Medical School

Udo Jonas's Academic­Influence.com Rankings

Udo Jonas's Degrees

Why Is Udo Jonas Influential?

Udo Jonas's Published Works

Published Works

What Schools Are Affiliated With Udo Jonas?

Udo Jonas's AcademicInfluence.com Rankings